RankingsPricing
  1. JP-listed companies
  2. Fuji Pharma Co.,Ltd.
  3. Financials
  4. EBITDA margin (%)

Fuji Pharma Co.,Ltd.【JP:4554】

Market cap
¥47.6B
P/E ratio
12.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEBITDA margin (%) YoY (%)
Sep 30, 202517.2+9.58%
Sep 30, 202415.7-2.49%
Sep 30, 202316.1-8.83%
Sep 30, 202217.6+15.63%
Sep 30, 202115.2+4.76%
Sep 30, 202014.5-12.43%
Sep 30, 201916.6-1.15%
Sep 30, 201816.8-2.29%
Sep 30, 201717.2+12.40%
Sep 30, 201615.3-3.46%
Sep 30, 201515.8+1.75%
Sep 30, 201415.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)